Quantcast

Latest Basal rate Stories

2014-05-15 16:27:59

--- Data Presented at the American Association of Clinical Endocrinologists 23rd Annual Scientific and Clinical Congress --- BRIDGEWATER, N.J., May 15, 2014 /PRNewswire/ -- Valeritas, makers of the V-Go® Disposable Insulin Delivery Device, announced interim analysis data from SIMPLE, a prospective observational study, today that suggest patients with Type 2 diabetes who switched to V-Go therapy from their previous baseline treatment of long-acting insulin with or without oral...

2014-01-29 12:27:15

LAUSANNE, Switzerland, January 29, 2014 /PRNewswire/ -- Click here for Picture 1 [http://www.debiotech.com/news/images/nw181_1.png ] The JewelPUMP2, which will be unveiled for the first time at the ATTD 2014 congress on February 5th in Vienna, is a new product dedicated to the Diabetes Type 2 market, based on Debiotech's innovative JewelPUMP platform. The JewelPUMP2 has been entirely re-designed to address the very specific market of Type 2 patients, requiring an...

2011-07-25 06:30:00

BRIDGEWATER, N.J., July 25, 2011 /PRNewswire/ -- Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it received CE Mark approval for its V-Go(TM) Disposable Insulin Delivery Device as well as ISO 13485: 2003 Quality Management System Certification. The V-Go is designed to provide simple basal-bolus therapy for adults who require insulin therapy. "These are important corporate milestones for...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related